In this discussion, we welcome Aytu BioPharma, NASDAQ ticker symbol AYTU. And with us today is their Chief Executive Officer, Josh Disbrow.

Aytu is a pharmaceutical company focused on commercializing novel therapeutics.

This Fireside Chat was recorded during the Lytham Partners Spring 2024 Investor Conference.